drugset
Drugs / multi-CMV epitope modified vaccinia Ankara vaccine
last change Jul 2017 re-read 3 minutes ago

multi-CMV epitope modified vaccinia Ankara vaccine

Vaccine

Developed for
cytomegalovirus infection
Investigated by
City of Hope Medical Center · National Cancer Institute (NCI)

Trials 1

today NCT01941056 · Ph 1
20142015201620172018201920202021202220232024202520262027
PhaseRegistry idDatesIndicationSponsorStatusOutcome
Phase 1 NCT01941056 Jan 2014 → Jul 2017 cytomegalovirus infection City of Hope Medical Center Completed No outcome recorded

Evidence & citations 3 cited values

Every value below carries the sentence it was read from. 1 source stands behind the page.

FieldValueCited text
Known as multi-CMV epitope modified vaccinia Ankara vaccine ClinicalTrials.gov intervention name — accepted as the source's own label NCT01941056 ↗
Modality Vaccine “multi-CMV epitope modified vaccinia Ankara vaccine” NCT01941056 ↗
Route Intramuscular “Participants receive multi-CMV epitope modified vaccinia Ankara vaccine intramuscularly (IM) followed by a booster injection 28 days later in the absence of unacceptable toxicity.” NCT01941056 ↗